Oyster Point Pharma Inc logo

OYST - Oyster Point Pharma Inc News Story

$20.45 -0.9  -4.2%

Last Trade - 16/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £401.3m
Enterprise Value £261.6m
Revenue £n/a
Position in Universe 3409th / 6850

BRIEF-Oyster Point Pharma Reports Q4 Loss Per Share $0.86

Thu 18th February, 2021 9:13pm
Feb 18 (Reuters) - Oyster Point Pharma Inc  OYST.O :
    * OYSTER POINT PHARMA REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * Q4 LOSS PER SHARE $0.86
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.79 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNXc29RQS 
Further company coverage:  OYST.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.